HK1

Chr 10ARAD

hexokinase 1

Also known as: CNSHA5, HK, HK1-ta, HK1-tb, HK1-tc, HKD, HKI, HMSNR

Hexokinase 1 catalyzes the phosphorylation of glucose to glucose-6-phosphate, the initial step of glycolysis, and localizes to the mitochondrial outer membrane where it links glucose metabolism to mitochondrial function. Mutations cause a spectrum of disorders including congenital nonspherocytic hemolytic anemia, neurodevelopmental disorder with visual defects and brain anomalies, hereditary motor and sensory neuropathy (Russe type), and retinitis pigmentosa. Inheritance is both autosomal recessive and autosomal dominant depending on the specific phenotype.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismAR/ADLOEUF 0.334 OMIM phenotypes
Clinical SummaryHK1
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.91). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
15 unique Pathogenic / Likely Pathogenic· 214 VUS of 400 total submissions
📖
GeneReview available — HK1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint
0.33LOEUF
pLI 0.915
Z-score 4.96
OE 0.19 (0.110.33)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
3.23Z-score
OE missense 0.61 (0.560.67)
341 obs / 555.3 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.19 (0.110.33)
00.351.4
Missense OE0.61 (0.560.67)
00.61.4
Synonymous OE0.94
01.21.6
LoF obs/exp: 8 / 43.2Missense obs/exp: 341 / 555.3Syn Z: 0.73
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongHK1-related neurodevelopmental disorder with visual defects and brain anomaliesOTHERAD
limitedHK1-related retinitis pigmentosaOTHERAD
DN
0.5280th %ile
GOF
0.5660th %ile
LOF
0.4430th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF53% of P/LP variants are LoF · LOEUF 0.33
GOF1 literature citation

Literature Evidence

GOFBiochemical assays showed that the E847K mutation does not affect hexokinase enzymatic activity or the protein stability, suggesting that the mutation may impact other uncharacterized function or result in a gain of function of HK1.PMID:25316723

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic12
VUS214
Likely Benign136
Benign11
Conflicting7
3
Pathogenic
12
Likely Pathogenic
214
VUS
136
Likely Benign
11
Benign
7
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
3
0
0
0
3
Likely Pathogenic
5
5
2
0
12
VUS
8
193
11
2
214
Likely Benign
0
2
55
79
136
Benign
0
2
7
2
11
Conflicting
7
Total162027583383

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

HK1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →